Biohaven Ltd. (BHVN)
(Delayed Data from NYSE)
$39.31 USD
+1.60 (4.24%)
Updated Feb 4, 2025 04:00 PM ET
After-Market: $39.30 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
03/06/2025
Time: -- |
12/2024 | $-1.56 | 0.00% |
Earnings Summary
For their last quarter, Biohaven Ltd. (BHVN) reported earnings of -$1.70 per share, missing the Zacks Consensus Estimate of -$1.67 per share. This reflects a negative earnings surprise of 1.80%. Look out for BHVN's next earnings release expected on March 06, 2025. For the next earning release, we expect the company to report earnings of -$1.56 per share, reflecting a year-over-year increase of 13.81%.
Earnings History
Price & Consensus
Zacks News for BHVN
SRRK Stock Soars as Muscle Disease Drug Meets Phase III Study Goal
BHVN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Biotech Stock Roundup: BHVN, WVE, ZVRA Stocks Up on Updates, BIIB & UCBs Study Data & More
BHVN Stock Up as Rare Neurological Disease Study Meets Primary Goal
Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipeline in Focus
BHVN FAQs
Based on past history, Zacks believes Biohaven Ltd. (BHVN) will report their next quarter earnings on March 06, 2025. For the next earning release, we expect the company to report earnings of -1.56 per share, reflecting a year-over-year increase of 13.81.
Based on past history, Zacks believes Biohaven Ltd. (BHVN) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on March 06, 2025.
The Zacks Consensus Estimate for Biohaven Ltd. (BHVN) for the quarter ending December 2024 is $-1.56 a share. We expect Biohaven Ltd. (BHVN) to report earnings in line with the consensus estimate of $-1.56 per share
In the earnings report for the quarter ending in June 2024, Biohaven Ltd. (BHVN) announced earnings of $-3.64 per share versus the Zacks Consensus Estimate of $-1.72 per share, representing a surprise of 111.63%.